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Mokola virus (MOKV) is a nonsegmented, negative-sense RNA virus that belongs to the Lyssavirus genus
and Rhabdoviridae family. MOKV phosphoprotein P is an essential component of the replication and tran-
scription complex and acts as a cofactor for the viral RNA-dependent RNA polymerase. P recruits the viral
polymerase to the nucleoprotein-bound viral RNA (N-RNA) via an interaction between its C-terminal domain
and the N-RNA complex. Here we present a structure for this domain of MOKV P, obtained by expression of
full-length P in Escherichia coli, which was subsequently truncated during crystallization. The structure has a
high degree of homology with P of rabies virus, another member of Lyssavirus genus, and to a lesser degree with
P of vesicular stomatitis virus (VSV), a member of the related Vesiculovirus genus. In addition, analysis of the
crystal packing of this domain reveals a potential binding site for the nucleoprotein N. Using both site-directed
mutagenesis and yeast two-hybrid experiments to measure P-N interaction, we have determined the relative
roles of key amino acids involved in this interaction to map the region of P that binds N. This analysis also
reveals a structural relationship between the N-RNA binding domain of the P proteins of the Rhabdoviridae and
the Paramyxoviridae.
Like rabies virus (RABV), Mokola virus (MOKV) belongs
to the Lyssavirus genus and the Rhabdoviridae family. Lyssavi-
ruses often cause lethal encephalitis and are a significant global
health risk. RABV alone is responsible for an estimated 55,000
deaths a year, primarily in poor rural areas in Africa and Asia
(26), in spite of the availability of effective vaccines. In addi-
tion, poor surveillance and the emergence of novel variants
that appear to be insensitive to traditional rabies vaccines
(such as MOKV) mean that the true risk that these viruses
pose remains underappreciated (44). Lyssaviruses belong to
the order Mononegavirales and have a nonsegmented, nega-
tive-sense (NNS) RNA genome that contains five common
genes in the following order: N (nucleoprotein), P (phospho-
protein), M (matrix protein), G (glycoprotein), and L (large
protein) (9). During all stages of the virus life cycle, their RNA
genome and RNA antigenome are encapsidated by N, which
forms a large helical polymer known as the nucleocapsid (13,
22). The replication/transcription complex is formed by L, P,
and N. The L protein harbors the RNA-dependent RNA poly-
merase (RdRP) catalytic activity but also caps and polyadeny-
lates the viral mRNA as shown for vesicular stomatitis virus
(VSV) (1, 33). The P protein fulfils a crucial role during RNA
synthesis, as it is an essential cofactor for the RdRP activity of
L. P contains a dimerization domain located between residues
91 and 131 (RABV P numbering) (15, 16, 23). Both structural
and biochemical analyses suggest that RABV P forms elon-
gated dimers in solution, which is in line with other evidence
suggesting an important role for dimerization in replication
(15). In addition, P binds two distinct forms of N, i.e., No and
N-RNA; No refers to a soluble form of N that is not associated
with RNA molecules, and N-RNA corresponds to the multim-
erized form of N associated with genomic RNA. There is
evidence that N° interacts with two distinct regions of P located
at the N terminus (RABV P residues 4 to 40) (7, 31) and C
terminus (RABV P residues 185 to 297) of the phosphoprotein
(7, 14). In contrast, only the C-terminal domain of P interacts
with N when it is bound to genomic RNA in the nucleocapsid
(16). The lyssavirus phosphoprotein is also phosphorylated
(20). Experimental evidence obtained for VSV further sug-
gests that the differential phosphorylation of the N and C
termini of P may be involved in regulating viral transcription
and replication (8). Conversely, N is also phosphorylated, but
the exact role of phosphorylation of these two proteins in
regulating their binding remains controversial (29, 45). Binding
of P to N-RNA probably involves the C-terminal region of N
(RABV N residues 376 to 450) (38). A recent model proposes
that during replication the L protein forms a complex with P,
which in turn binds to the N-RNA polymer and acts as a bridge
to allow access of L to the RNA. The model further suggests
that the P-N0 complex may bind to the replicating L-P-N-RNA
complex and feed the newly formed RNA strand with uncom-
plexed N for immediate encapsidation (1). However, it is im-
* Corresponding author. Mailing address: UPRE Lyssavirus Dy-
namics and Host Adaptation, WHO Collaborating Centre for Refer-
ence and Research on Rabies, Institut Pasteur, 75724 Paris Cedex 15,
France. Phone: 33 1 45 68 87 85. Fax: 33 1 40 61 30 20. E-mail:
hbourhy@pasteur.fr.
 Published ahead of print on 11 November 2009.
1089
 o
n
 January 26, 2017 by INSTITUT PASTEUR-Bibliotheque
http://jvi.asm.org/
D
ow
nloaded from
 
portant to note that many of the details of the interactions
between L, P, and N in the context of the replication or tran-
scription complexes are not well understood. This is due pri-
marily to the lack of high-resolution structural data about these
proteins and their complexes. To date the structures of the
VSV and RABV N-RNAs have been determined (2, 19), as
well as individual domains of the VSV and RABV P proteins
(specifically the dimerization domain of VSV P and the N-
RNA binding domains of VSV and RABV P) (10, 30, 36). Very
recently the structure of VSV N-RNA complexed with the
C-terminal domain of VSV P has been determined, which
reveals that P binds in the cleft between two adjacent N mol-
ecules in the nucleocapsid (18) primarily via helix 4 and
residues in 2. In contrast, no high-resolution structural data
are available for L. The structure of the RABV P N-RNA
binding domain in combination with previous studies of P-N
complexes has led to a tentative model for the interaction
between RABV N-RNA and P (1, 37). However, the lack of
structural data means that the exact nature of the interactions
remains uncertain.
Because the functional analysis of P in the L-P-N-RNA
complex remains incomplete, we crystallized full-length
MOKV P to better define the structure of this protein. Here
we present a structure of the C-terminal domain of MOKV P,
which is involved in the interaction with N, obtained by expres-
sion of full-length P in Escherichia coli, which was subsequently
truncated during crystallization. The structure shows a high
degree of homology with the RABV P. The details of the
contacts between molecules of P in the crystal reveal that the
C-terminal acidic tail specific to MOKV P and absent in
RABV P packs against a positively charged surface area of P
that may represent the N-RNA binding site. On the basis of
this structure, we tested a number of amino acid residues
potentially involved in P–N-RNA interaction, by yeast two-
hybrid analysis. Using this strategy, we have been able to define
a number of residues in the C-terminal domain of P, mutations
of which block binding to N.
MATERIALS AND METHODS
Cloning. For in-fusion cloning, the cDNA of the gene encoding the phospho-
protein of Mokola virus was obtained by reverse transcription-PCR (RT-PCR)
from total RNA isolated from infected BSR cells (a clone of BHK-21) using
hexamer primers (Roche Boehringer). PCR was carried out with the primers
5-AGGAGATATACCATGAGCAAAGATTTGGTGCATCCTAGTC-3 and 5-
GTGATGGTGATGTTTCTCTGCCTCCTCGAGCCGGGC-3, where the gene-
specific sequence is indicated in bold. The PCR product was cloned into pOPINE
using the in-fusion cloning methodology (6), yielding a full P construct with a
C-terminal 6His tag.
For cloning of the target and bait proteins for the yeast two-hybrid experi-
ments the same cDNA was also used to amplify by PCR the DNA sequence
encoding full-length N and P176, which corresponds to P deleted of the first 176
amino acids. The following pairs of primers were used: 5-GGGGACAACTTT
GTACAAAAAAGTTGGCATGGAGTCTGACAAGATTGTG-3 and 5-GGGG
ACAACTTTGTACAAGAAAGTTGGTTATGATCCATCTGCATACAC-3 for
N and 5-GGGGACAACTTTGTACAAAAAAGTTGGCATGCACACACCCG
ATCACGATG-3 and 5-GGGGACAACTTTGTACAAGAAAGTTGGTTACT
CTGCCTCCTCGAGC-3 for P176. The gene-specific sequence is indicated in
bold. PCR products were cloned into pDONR207 (Invitrogen) using Gateway.
Site-directed mutagenesis was performed with the QuikChange site-directed mu-
tagenesis kit (Stratagene) following the manufacturer’s instructions, using P176
cloned into pDON207 as a template for PCR. Primers used for site-directed mutagen-
esis were the following: P176(F210A), 5-GCCCATCAGGTAGCAGAAAGCGCT
TCAAAGAAATACAAGTTCCC-3 and 5-GGGAACTTGTATTTCTTTGAAGC
GCTTTCTGCTACCTGATGGGC-3; P176(S211A), 5-CATCAGGTAGCAGAA
AGCTTTGCAAAGAAATACAAGTTCCCTT-3 and 5-AAGGGAACTTGTATT
TCTTTGCAAAGCTTTCTGCTACCTGATG-3; P176(K212E), 5-CATCAGGTA
GCAGAAAGCTTTTCAGAGAAATACAAGTTCCCTT-3 and 5-AAGGGAACT
TGTATTTCTCTGAAAAGCTTTCTGCTACCTGATG-3; P176(K212A), 5-CA
TCAGGTAGCAGAAAGCTTTTCAGCGAAATACAAGTTCCCTTCTAGA
TC-3 and 5-GATCTAGAAGGGAACTTGTATTTCGCTGAAAAGCTTTCT
GCTACCTGATG-3; P176(K213E), 5-GGTAGCAGAAAGCTTTTCAAAG
GAATACAAGTTCCCTTCTAGATC-3 and 5-GATCTAGAAGGGAACTT
GTATTCCTTTGAAAAGCTTTCTGCTACC-3; P176(K213A), 5-GGTAG
CAGAAAGCTTTTCAAAGGCATACAAGTTCCCTTCTAGATCC-3 and 5-
GGATCTAGAAGGGAACTTGTATGCCTTTGAAAAGCTTTCTGCTACC-
3; P176(Y214E), 5-CAGGTAGCAGAAAGCTTTTCAAAGAAAGAAAA
GTTCCCTTCTAGATCCTC-3 and 5-GAGGATCTAGAAGGGAACTTTT
CTTTCTTTGAAAAGCTTTCTGCTACCTG-3; P176(Y214A), 5-CCATCA
GGTAGCAGAAAGCTTTTCAAAGAAAGCCAAGTTCCCTTCTAGA
T-3 and 5-ATCTAGAAGGGAACTTGGCTTTCTTTGAAAAGCTTTCTGC
TACCTGATGG-3; P176(K215E), 5-AGCAGAAAGCTTTTCAAAGAAAT
ACGAGTTCCCTTCTAGATCC-3 and 5-GGATCTAGAAGGGAACTCGT
ATTTCTTTGAAAAGCTTTCTGCT-3; P176(K215A), 5-GGTAGCAGAA
AGCTTTTCAAAGAAATACGCGTTCCCTTCTAGATCCTCG-3 and 5-CG
AGGATCTAGAAGGGAACGCGTATTTCTTTGAAAAGCTTTCTGCTACC-
3; P176(I223E), 5-CCCTTCTAGATCCTCGGGAGAATTCTTGTGGAAC
TTTGAG-3 and 5-CTCAAAGTTCCACAAGAATTCTCCCGAGGATCTA
GAAGGG-3; P176(L225E), 5-CTAGATCCTCGGGAATATTCGAGTGG
AACTTTGAGCAGCTTA-3 and 5-TAAGCTGCTCAAAGTTCCACTCGA
ATATTCCCGAGGATCTAG-3; and P176(Y295F), 5-CCAAGAAGATAT
CAACAGTTTCATGGCCCGGCTCG-3 and 5-CGAGCCGGGCCATGAAA
CTGTTGATATCTTCTTGG-3.
Expression and purification. The P protein was expressed and purified using
standard methods as described previously (35). Briefly, E. coli expressing MOKV
P was grown in 0.5 L of TB Overnight Express (Novagen) for 5 to 6 h at 37°C
followed by 20 h at 25°C. The cell pellet was harvested and frozen at 80°C. For
protein purification, the pellet was defrosted on ice and resuspended in buffer A
(25 mM Tris [pH 7.5], 500 mM NaCl, 30 mM imidazole) with 0.1% Tween 20,
protease inhibitors, and DNase I added. The suspension was passed through a
cell disruptor at 30 kpsi and then centrifuged for 30 min at 30,000  g at 4°C. The
soluble fraction was transferred to an Akta¨ Express equipped with an Ni-nitrilo-
triacetic acid (NTA) column connected in-line to a Hiload 16/60 Superdex 75 gel
filtration column (GE Healthcare). The Ni-NTA column was washed using buffer
A, eluted using buffer B (25 mM Tris [pH 7.5], 250 mM NaCl, 250 mM imida-
zole) before transfer to the gel filtration column equilibrated in buffer C (20 mM
Tris [pH 7.5], 200 mM NaCl). Peak fraction collection was performed using the
Akta¨ Express software. Peak fractions were pooled, and the protein was concen-
trated to 12 mg/ml. The integrity of the protein was verified by electrospray
ionization (ESI) mass spectroscopy as described previously (35).
Crystallization, data collection, and structure determination. The concen-
trated protein was subjected to the OPPF automated sitting-drop vapor diffusion
crystallization pipeline as described previously (48). Crystallization trials were
attempted at 20.5°C in sitting drops containing 100 nl protein and 100 nl pre-
cipitant solution equilibrated against 95-l reservoirs in 96-well plates. In total,
576 conditions were tested. Diffraction-quality crystals appeared after 15 days in
a condition containing 30% (vol/vol) pentaerythritol ethoxylate (15/4 EO/OH),
50 mM ammonium sulfate, and 100 mM bis-Tris, pH 6.5 (Hampton Index
screen).
Crystals were cryoprotected by brief immersion in reservoir solution supple-
mented with 20% (vol/vol) glycerol before flash-cryocooling in a stream of cold
(100 K) nitrogen gas. The diffraction quality of the crystal was significantly
improved by annealing, i.e., blocking the cryogenic gas stream with a credit card
for 5 s (3). Diffraction data were recorded from a single crystal at the I03
Diamond beamline ( 	 0.890 Å) on a Quantum 315 detector (Area Detector
Systems Corporation) and processed using HKL2000. The structure was solved
by molecular replacement using the structure of the RABV P N-RNA binding
domain (Protein Data Bank [PDB] accession no. 1VYI) with Molrep (46) and
TLS
 restrained refinement at 2.1 Å (0.21 nm) completed using REFMAC (32).
Refinement statistics are shown in Table 1. Structure-based superpositions were
performed using SHP (40), and sequence alignments carried out with ClustalX
(43) or MUSCLE (12). Graphics were produced using PYMOL (http://www
.pymol.org/).
Yeast two-hybrid procedure. Yeast culture media were prepared as previously
described (47). P176 or the appropriate mutants were transferred by in vitro
recombination from pDONR207 in a Gateway-compatible pDEST32 yeast ex-
pression vector (Invitrogen) to be fused with the DNA binding domain of Gal4
(Gal4DB). N protein was transferred from pDONR207 into pPC86 (Invitrogen)
1090 ASSENBERG ET AL. J. VIROL.
 o
n
 January 26, 2017 by INSTITUT PASTEUR-Bibliotheque
http://jvi.asm.org/
D
ow
nloaded from
 
to be fused to the activation domain of Gal4 (Gal4AD). These constructs were
transformed in yeast strain AH109 (Clontech). Yeast cells were plated on a
selective medium lacking histidine and supplemented or not with the indicated
amount of 3-aminotriazole (3-AT) (Sigma-Aldrich) to test the interaction-de-
pendent transactivation of the HIS3 reporter gene.
Protein structure accession number. The final refined coordinates and struc-
ture factors have been deposited with the PDB under accession number 2wzl.
RESULTS
Crystallization of MOKV P and structure determination.
We expressed full-length MOKV P in E. coli and, following
purification, subjected it to nanodrop crystallization trials. Dif-
fraction-quality crystals formed within 15 days, and the 2.1-Å
structure was determined by molecular replacement using the
structure of the RABV P N-RNA binding domain (PDB ac-
cession no. 1VYI [30]) and refined with residuals Rwork/Rfree of
0.220/0.266. The crystal structure belongs to space group
P212121, with cell dimensions a 	 25.8 Å, b 	 48.9 Å, and c 	
86.0 Å, and reveals one copy of a truncated form of P in the
asymmetric unit. The region of P crystallized is the C-terminal,
N-RNA binding domain (residues 197 to 303), and the exper-
imental electron density shows a sharp cutoff at residue 197,
suggesting that this is where the truncation occurred.
The refined model for residues 197 to 303 is complete and
has good stereochemistry (Table 1), with more than 90% of
residues in the most favored region of the Ramachandran plot
(28). The data show that P had been truncated during the
crystallization process, as mass spectrometry analysis of the
protein immediately before the crystallization trials showed
the protein to be intact at that point (data not shown). It is
interesting to note that the previously published structure of
the rabies virus C-terminal domain of P was obtained by ex-
pression of full-length P in insect cells, which was subsequently
also truncated during the crystallization process (30).
Analysis of MOKV P structure. The structure of the MOKV
P C-terminal domain is formed by six tightly folded  helices,
a 310 helix, and a small  sheet consisting of two  strands (Fig.
1), with a morphology previously described as resembling a
sliced pear, with a flat and curved face. It shows a high degree
of structural homology with RABV P (PDB accession no.
1VYI) (Fig. 1B) (101 amino acids aligned with a root mean
square deviation [RMSD] of 0.66 Å using SHP [40]), consistent
with the high degree of sequence identity (68%). As the first
residue visible in the electron density is residue 197, this means
that the MOKV P structure is 10 amino acids shorter at the N
terminus than the available RABV P structure (which starts at
residue 187), yielding a shorter 1 helix. In addition, there are
five extra residues at the C terminus compared to RABV P,
leading to an extended 6 helix. Apart from the N- and C-
terminal extremities of the P structures, the MOKV and
RABV P proteins have very similar structures (Fig. 1) with
similar surface charge properties. As observed for RABV P, a
clear positively charged cluster is present on the round face of
MOKV P, which is implicated in binding N (23), whereas for
the flat face the charge is more evenly distributed. The so-
called “W hole,” present on the flat face, which has been
implicated in binding N (although no direct evidence exists to
support this [30]), is formed by three residues (C262, F266, and
I288 in MOKV P and C261, W265, and M287 in RABV P). In
the Mokola virus structure, however, this hole is not as pro-
nounced as it is in the RABV P structure, where W186, from
a neighboring molecule, packs into the hole and displaces
W265. The role of this hydrophobic region, if any, remains
unclear.
There is also clear structural similarity to P of VSV, al-
though the fragment of VSV P solved by nuclear magnetic
resonance (NMR) is considerably smaller. In this case SHP
aligns 57 residues out of 70 in VSV, with an RMSD of 2.73 Å,
despite the aligned residues sharing less than 11% sequence
identity.
Mapping the P-N binding site. Analysis of the crystal struc-
ture of MOKV P using PISA (27) reveals that the major crystal
FIG. 1. Side-by-side comparison of rhabdovirus P structures:
(A) MOKV P; (B) RABV P (PDB accession no. 1VYI); (C) VSV P
(PDB accession no. 2K47). The structures are rainbow ramped from
blue (N terminus) to red (C terminus).
TABLE 1. X-ray data collection and refinement statistics
Parameter Value
Data collection
X-ray source .......................................................Diamond I03
Wavelength (Å)..................................................0.890
Space group ........................................................P212121
Unit cell (Å) .......................................................a 	 25.84, b 	 48.87,
c 	 85.95
Resolution range (Å) ........................................30.0-2.10 (2.18-2.10)
Unique reflections..............................................6,812 (653)
Completeness (%) .............................................99.6 (97.9)
Redundancy ........................................................5.5 (3.3)
Avg I/I ...............................................................9.9 (1.7)
Rmerge ...................................................................0.173 (0.585)
Refinement statistics
Resolution range (Å) ........................................30.0-2.10 (2.18-2.10)
No. of reflections (working/test) ......................6,454/325
R factora (Rwork/Rfree)........................................0.220/0.266
No. of atoms (protein/water)............................851/59
Bond length RMSD (Å) ...................................0.007
Bond angle RMSD (°).......................................0.9
Mean B factor (protein/water; Å2)..................17/32
a Rwork and Rfree are defined by R	 hkl¦¦Fobs ¦ ¦Fcalc¦¦/hkl ¦Fobs¦, where
h, k, and l are the indices of the reflections (used in refinement for Rwork; 5%, not
used in refinement, for Rfree) and Fobs and Fcalc are the structure factors deduced
from measured intensities and calculated from the model, respectively. Numbers
in parentheses are for the highest-resolution shell.
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packing interface involves the positively charged cluster impli-
cated in N-RNA binding (23). Specifically, the interface is
established primarily by the interactions of the C-terminal 6
helices of two symmetry-related monomers (symmetry opera-
tor: x1/2,y
3/2,z), orientated in an inverted fashion rel-
ative to each other (Fig. 2A). The C-terminal four residues
(E300, E301, A302, and E303) of one monomer (drawn in
yellow in Fig. 2) interact, via a combination of both polar and
hydrophobic contacts, with a positively charged region consist-
ing of residues located on 1, 2, 4, and 6 (K212, K213,
Y214, K215, I223, L225, R261, and Y295) in the other mono-
mer (drawn in green in Fig. 2A and B). K212, K213, K215,
R261, and Y295 engage in both main- and side-chain polar
contacts with the acidic tail, with Y214, K215, I223, L225, and
R261 contributing to additional hydrophobic interactions (Ta-
ble 2). This interaction probably does not occur under physi-
ological conditions because the interaction surface is small,
with a total buried surface area between the two monomers of
757.4 Å2 and 392.3 Å2 contributed by the acidic tail. This is
further supported by the observation that the acidic extension
of MOKV P is poorly conserved among the lyssaviruses. A
total of 384 GenBank sequences of P that encompass at least
the motif described here and represent all the described ge-
notypes of lyssaviruses were aligned using ClustalX (available
on request). Of all lyssaviruses characterized to date, only
MOKV (L-E-E/D-A-D/E), Lagos bat virus (L-E-E/D-A/V/I-
D), and raccoon rabies virus (R-Q-L-N-L) P proteins contain a
similar extension.
Strikingly, K212, K213, Y214, and K215 were previously
identified as being involved in the interaction with N-RNA
FIG. 2. Details of the major crystal packing interaction interface. (A) View of the interaction between the two neighboring monomers.
(B) Close-up of the interactions between the positively charged cluster located on one monomer (green) with the acidic C terminus of the second
monomer (yellow). (C) The same view as in panel B but with the green monomer shown as an electrostatic surface representation, generated using
the PDB2PQR server (using the AMBER force field [11]) in combination with APBS tools (4) and pymol (http://www.pymol.org/).
TABLE 2. PISA analysis of the MOKV P-P interface
Structure Residue Bondsa No. of bonds Accessible surfacearea (Å2)
Buried surface
area (Å2) 
iG (kcal/M)b Yeast two-hybridresultsc
1 Lys 212 HS 1 113.9 35.5 0.72 


Lys 213 H 1 107.97 23.99 0.12 
Tyr 214 36.74 27.25 0.44 


Lys 215 HS 3 111.52 84.8 1.07 


Ile 223 109.32 28.72 0.46 
Leu 225 95.81 28.48 0.46 

Arg 261 H 1 55.12 46.99 0.64 


Tyr 295 H 1 72.9 37.33 0.02 
2 Glu 300 H 3 141.8 133.95 0.46 ND
Glu 301 HS 2 104.71 56.01 0.1 ND
Ala 302 H 1 107.22 54.08 0.69 ND
Glu 303 S 1 215.04 62.45 -0.19 ND
a H, hydrogen bond; S, salt bridge.
b iG, solvation energy gain upon formation of the interface.
c , no effect; 
, weak effect; 

, strong effect; ND, not determined.
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(23). Moreover, the acidic tail bears a striking resemblance to
the acidic region in N (DEED in MOKV N versus EEAE in
MOKV P) immediately following S389, whose phosphorylation
status may modulate the interaction of N with P (45).
To precisely map which amino acid residues of the MOKV
P domain are involved in this interaction with N, we mutated
the eight amino acids (K212 to 215, I223, L225, R261, and
Y295) implicated in the interaction with the acidic tail of P.
F210 and S211, which were previously postulated to play a role
in P-N interaction, were also tested (23). Yeast cells were
transformed with Gal4DB-P and Gal4AD-N, and the absence
of toxicity when expressing these two proteins was assessed on
synthetic medium without leucine and tryptophan (LW).
P-N interaction was monitored by measuring yeast growth on
the same medium but without histidine (LWH) and sup-
plemented or not with 3-AT to increase stringency. The inter-
action between P and N was tested by yeast two-hybrid exper-
iments between full-length MOKV N and truncated MOKV P
lacking amino acids 1 to 176 (P176) to remove both the P-N°
interaction site in the N-terminal part of P and the dimeriza-
tion domain (7, 16, 31). This approach is similar to the exper-
iments conducted previously by Jacob et al. (23) but with the
important difference that we introduced specific, single muta-
tions whereas Jacob et al. used a random mutagenesis ap-
proach yielding constructs with multiple substitutions.
As shown in Fig. 3, mutations of Y214, K215, and R261
resulted in the most significant growth defects of the yeast
strain, while for K212 and L225 higher-stringency conditions
were necessary to reveal an effect on N binding. The number of
bonds formed and the reduction in accessible surface area
upon binding the acidic tail of each of the residues shows a
good overall correspondence with the Y2H results (Table 2).
These results suggest that these residues are involved in the
interaction between MOKV P and N. However, it should be
noted that it is distinctly possible that the Y214E mutation
causes incorrect protein folding, given the packing of this ar-
omatic side chain in the core of the molecule. Table 2 shows
that the accessible surface area of Y214 in the unbound state
is low (36.74Å2) and is reduced only slightly upon binding
the acidic tail (27.25Å2), indicative of a weak interaction with
the tail and burial of a significant portion into the core of the
protein. Similarly, increasing the stringency by the addition of
3-AT revealed that the Y214A mutation did impair yeast
growth, but whether this is due to the effects on P-N complex
stability or destabilization of P remains to be seen.
For residues K212, K215, L225, and R261 the MOKV and
RABV P structures show that the effects observed are not likely
due to a defect in P folding but are likely due to disruption of the
interaction with N. Figure 3 clearly reveals the importance of the
electrostatic environment in the interaction, as mutations of these
residues to glutamic acid had a much more substantial effect on
disrupting the interaction with N than alanine substitution. This
further supports the idea that the interaction observed for P in the
crystal with its acidic tail mimics the interaction with N, as the
crystal structure showed that the interaction with the acidic tail
was largely electrostatically driven and involved primarily main-
chain atoms of the acidic tail.
DISCUSSION
We have crystallized and solved the structure of the N-RNA
binding domain of Mokola virus P via expression of full-length
P which was subsequently truncated during the crystallization
process. The MOKV P structure shows a high degree of struc-
tural similarity with the homologous domain of RABV P, con-
sistent with the high degree of sequence identity (68%). Due to
the longer sequence of MOKV P compared to RABV P, the
C-terminal alpha helix (6) is six residues longer than that of
RABV P. Whether the MOKV P 1 in the intact protein is
longer than observed here remains to be established, as the
sequence prior to residue 197 is poorly conserved between the
RABV and MOKV P proteins and secondary structure pre-
diction methods do not predict the presence of a helix even for
RABV P in this region.
Analysis of the crystal packing interactions revealed that a
positively charged region of P, previously shown to be involved
in the interaction with N, interacts with four acidic C-terminal
amino acids in a symmetry-related P molecule that may resem-
ble part of the putative P binding region in N. The interaction
is electrostatically driven and, together with the small buried
surface area, suggests that the interacting regions in P and/or N
are likely to be larger than can be ascertained on the basis of
the MOKV P crystal structure alone, consistent with the recent
structure of VSV N-RNA in complex with P indicating that the
opposing face of the domain in P, involving helices 4 and 5,
is involved in the interaction with N (18, 37, 38). The involve-
ment of the positively charged region in P in binding N was
further confirmed by a combination of site-directed mutagen-
esis and yeast two-hybrid analysis to study the effects of the
mutations on the interaction of MOKV P with MOKV N. The
analysis revealed that out of 10 amino acids in P potentially
involved in binding N, five negatively affected the P-N inter-
FIG. 3. Mapping the P-N interaction by yeast two-hybrid analysis.
Yeast cells expressing Gal4 DNA binding domain (Gal4DB) fused to
wild-type P176 (WT) or the indicated mutants were cotransformed
with a plasmid encoding the Gal4 transactivation domain (AD) alone
(empty vector) or fused to N. Yeast cells were plated on selective
medium lacking leucine and tryptophan to validate yeast growth after
transformation (LW). Selective medium lacking histidine and sup-
plemented with indicated concentrations of 3-aminotriazole (3-AT)
were used to test the interaction-dependent transactivation of the
HIS3 reporter gene.
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action. As previously demonstrated (23), we confirmed that
K212, K215, and perhaps Y214 are involved in P-N binding.
We further show that a positive charge at positions 212 and 215
is crucial for P-N interaction. Two other positions not previ-
ously described, L225 and R261, were also shown to be nec-
essary for the P-N interaction to occur. However, our work
suggests that the role of amino acids 210, 211, and 213, recog-
nized as potentially involved in P-N binding, is less significant
(or at least they contribute less to the interaction with N), as
their mutation did not alter the interaction. This further rein-
forces the hypothesis of potential core packing destabilization
(30) of some mutations when generated at random since, only
a small number of the residues of P identified show here a clear
effect on N binding in the yeast two-hybrid screen when tested
in isolation. The high degree of conservation of these positions
in lyssaviruses despite the high variability of this region of the
P further supports their importance in the interaction with N.
The observation that at all sites alanine substitutions are tol-
erated in the interaction with N indicates that the acidic tail-
positive cluster interactions are probably weak and therefore
mutations in this region may be compensated for by the pres-
ence of other interacting regions in P and/or N.
The region of N interacting with P probably involves residues in
the vicinity of S389, as its phosphorylation state may be important
for the interaction with P (45) and trypsin removal of RABV N
residues 376 to 450 abolishes P binding (16, 38). S389 is followed
by four acidic residues with a high degree of similarity with the
acidic C-terminal extension of MOKV P (DEED in MOKV N
versus EEAE in MOKV P). However, mutation of all four acidic
residues in MOKV N (D390A, E391A, E392A, and D393A) did
not affect binding of N to P176 in a yeast two-hybrid screen (not
shown). Another acidic region in N is also highly conserved
among N proteins (ELEE in MOKV N, positions 371 to 374).
Here again mutations E373A and E374A did not alter P-N bind-
ing in yeast two-hybrid experiments (not shown). One or both of
these sites may still interact with P, since it has recently been
shown that measles virus (MeV) N has two boxes of amino acid
residues that are involved in P-N binding (5). However, MOKV N
mutated at both sites (residues 373 to 374 and 390 to 393) still
binds to MOKV P176 (not shown). This lack of effect on bind-
ing of P by mutating individually or in combination the two acidic
regions of N may reflect the fact that these regions are simply not
involved in P-N binding or that the P binding region involves
more than just the acidic residues mutated in this study, as sug-
gested by the structure of the VSV N-RNA P complex (18).
Given that, in our model, much of the molecular interaction of
the negatively charged tail involves main-chain atoms, it remains
possible that replacement of even the entire acidic region with
alanine is not sufficient to destabilize the interaction with P, as a
significant number of main-chain contacts with P are likely to
remain in place, as shown for VSV (18).
None of the MOKV P residues identified in this study as
being important for the interaction with MOKV N appear to
be conserved in the VSV P structure, suggesting that VSV P
interacts differently with N than the lyssavirus P. In addition,
biochemical data also indicate that P-N and P-L interactions
are likely to be different (41, 42). This has been confirmed by
the structure of VSV N-RNA complexed with the C-terminal
domain of VSV P, which reveals that those residues of VSV P
that are involved in binding lie close to but do not map directly
onto the residues that we predict are involved in MOKV N-P
binding (18). This lack of agreement is probably due primarily
to differences in the sizes of the P proteins (the C-terminal
domain of MOKV P is 50% larger than the equivalent C-
terminal domain of VSV).
Alongside the structures of the N-RNA binding domains
from P proteins of members of the Rhabdoviridae (MOKV and
RABV for the Lyssavirus genus and VSV P for the Vesiculo-
virus genus), the structures of functionally equivalent domains
of the P proteins from other members of the order Mononega-
virales have been solved. The structures of the N-RNA binding
domains of Sendai virus (SeV) and measles virus (MeV) P
proteins consist of an antiparallel triple-helix bundle, and, as
for the Rhabdoviridae, the N-RNA binding domains among
paramyxoviruses are also structurally conserved in spite of low
sequence conservation (5, 21, 24, 25). Careful analysis of the
structures reveals a structural relationship between the
N-RNA binding domains of the P proteins of the Rhabdoviri-
dae and the Paramyxoviridae, where the three-helix bundles of
the SeV and MeV P proteins align with helices 3, 4, and 6
FIG. 4. Comparison of the structures of Rhabdovirus and Paramyxovirus N-RNA binding domains of P. (A) Superposition of the conserved
elements of MOKV P (orange), VSV P (yellow) (PDB accession no. 2K47), and SeV (magenta) (PDB accession no. 1R4G). Helix numbering is
as for MOKV P. The left-hand drawing is based on SHP alignment of the C’s (40) whereas the right hand drawing is based on the sequence
alignment. (B) Side-by-side comparison of the conserved elements of the SeV, MOKV, and VSV P proteins.
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of MOKV (and RABV) (Fig. 4B). Structural superposition
using SHP (40) shows that 43 and 40 residues of MOKV P (out
of 107) can be aligned with SeV P and MeV P, with RMSDs of
3.3 Å and 3.2 Å, respectively, over the aligned residues, despite
14% and 0% sequence identity. The similarity between VSV P
and the paramyxovirus and lyssavirus P proteins is much
poorer due to a shorter C-terminal helix 4 and the absence of
a helix equivalent to MOKV 3 in VSV P, although the align-
ment suggests that at least VSV P 3 (4 in MOKV P) is
conserved. This low but detectable degree of structural simi-
larity would suggest that the P proteins of Rhabdoviridae and
Paramyxoviridae originated from a common ancestor in spite of
the high degree of amino acid divergence.
Finally, it is of interest to note that the MOKV P positively
charged cluster (K212, K213, and K215) in combination with
R261 was recently identified as a functional nuclear localiza-
tion signal (NLS) (34). Although the possible role of P nuclear
localization remains to be established, the structures of the
RABV and MOKV P proteins show that these regions do not
conform to the classic NLS structure (39), as they are not part
of a disordered or flexible loop but rather are part of an
ordered region that includes beta sheet 1, the (ordered) loop
separating 1 and 1, and helix 4. As noted by Pasdeloup et
al. (34), the overlap with the NLS suggests that the N-RNA
binding region in P may additionally act to mask the NLS upon
binding to N. If verified, this would constitute another example
of the modulation of the biological activities achieved by a
lyssavirus protein by sequestering a biologically active protein
interface during morphogenesis and/or the viral life cycle, as
already postulated for the matrix protein (17).
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